Loading...

Pan Kathy

Title(s)Member, CTSI
SchoolCTSI
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Pan K, Bosserman L, Chlebowski RT. Reply to F. Conforti et al. J Clin Oncol. 2019 Jul 20; 37(21):1840-1841. PMID: 31173556.
      View in: PubMed
    2. Pan K, Gong J, Huynh K, Cristea M. Current Systemic Treatment Landscape of Advanced Gynecologic Malignancies. Target Oncol. 2019 06; 14(3):269-283. PMID: 31069647.
      View in: PubMed
    3. Pan K, Luo J, Aragaki AK, Chlebowski RT. Weight loss, diet composition and breast cancer incidence and outcome in postmenopausal women. Oncotarget. 2019 May 03; 10(33):3088-3092. PMID: 31139321.
      View in: PubMed
    4. Pan K, Nelson RA, Wactawski-Wende J, Lee DJ, Manson JE, Aragaki AK, Mortimer JE, Phillips LS, Rohan T, Ho GYF, Saquib N, Shadyab AH, Nassir R, Rhee JJ, Hurria A, Chlebowski RT. Insulin Resistance and Cancer-Specific and All-Cause Mortality in Postmenopausal Women: The Women's Health Initiative. J Natl Cancer Inst. 2019 Apr 26. PMID: 31184362.
      View in: PubMed
    5. Michels KA, Brinton LA, Wentzensen N, Pan K, Chen C, Anderson GL, Pfeiffer RM, Xu X, Rohan TE, Trabert B. Postmenopausal Androgen Metabolism and Endometrial Cancer Risk in the Women's Health Initiative Observational Study. JNCI Cancer Spectr. 2019 Sep; 3(3):pkz029. PMID: 31321379.
      View in: PubMed
    6. Trabert B, Michels KA, Anderson GL, Brinton LA, Falk RT, Geczik AM, Harris HR, Pan K, Pfeiffer RM, Qi L, Rohan T, Wentzensen N, Xu X. Circulating androgens and postmenopausal ovarian cancer risk in the Women's Health Initiative Observational Study. Int J Cancer. 2019 Oct 15; 145(8):2051-2060. PMID: 30684389.
      View in: PubMed
    7. Pan K, Bosserman LD, Chlebowski RT. Ovarian Suppression in Adjuvant Endocrine Therapy for Premenopausal Breast Cancer. J Clin Oncol. 2019 Apr 10; 37(11):858-861. PMID: 30742565.
      View in: PubMed
    8. Iyengar NM, Arthur R, Manson JE, Chlebowski RT, Kroenke CH, Peterson L, Cheng TD, Feliciano EC, Lane D, Luo J, Nassir R, Pan K, Wassertheil-Smoller S, Kamensky V, Rohan TE, Dannenberg AJ. Association of Body Fat and Risk of Breast Cancer in Postmenopausal Women With Normal Body Mass Index: A Secondary Analysis of a Randomized Clinical Trial and Observational Study. JAMA Oncol. 2019 Feb 01; 5(2):155-163. PMID: 30520976.
      View in: PubMed
    9. Chlebowski RT, Mortimer JE, Crandall CJ, Pan K, Manson JE, Nelson R, Johnson KC, Vitolin MZ, Lane D, Wactawski-Wende J, Kwan K, Stefanick ML. Persistent vasomotor symptoms and breast cancer in the Women's Health Initiative. Menopause. 2018 12 28; 26(6):578-587. PMID: 30601454.
      View in: PubMed
    10. Uche A, Vankina R, Gong J, Cho M, Yeh JJ, Kim P, Pan K. Capecitabine-induced hypertriglyceridemia: a rare but clinically relevant treatment-related adverse event. J Gastrointest Oncol. 2018 Dec; 9(6):1213-1219. PMID: 30603144.
      View in: PubMed
    11. Chlebowski RT, Pan K. Adjuvant Endocrine Therapy for Premenopausal Breast Cancer. N Engl J Med. 2018 Oct 25; 379(17):1684. PMID: 30358972.
      View in: PubMed
    12. Chlebowski RT, Aragaki AK, Anderson GL, Simon MS, Manson JE, Neuhouser ML, Pan K, Stefanic ML, Rohan TE, Lane D, Qi L, Snetselaar L, Prentice RL. Association of Low-Fat Dietary Pattern With Breast Cancer Overall Survival: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trial. JAMA Oncol. 2018 10 01; 4(10):e181212. PMID: 29800122.
      View in: PubMed
    13. Arthur R, Kabat GC, Kim MY, Ho GYF, Chlebowski RT, Pan K, Rohan TE. Adiposity, history of diabetes, and risk of pancreatic cancer in postmenopausal women. Ann Epidemiol. 2019 01; 29:23-29.e1. PMID: 30449532.
      View in: PubMed
    14. Beverly CM, Naughton MJ, Pennell ML, Foraker RE, Young G, Hale L, Feliciano EMC, Pan K, Crane TE, Danhauer SC, Paskett ED. Change in longitudinal trends in sleep quality and duration following breast cancer diagnosis: results from the Women's Health Initiative. NPJ Breast Cancer. 2018; 4:15. PMID: 29978034.
      View in: PubMed
    15. Gong J, Pan K, Fakih M, Pal S, Salgia R. Value-based genomics. Oncotarget. 2018 Mar 20; 9(21):15792-15815. PMID: 29644010.
      View in: PubMed
    16. Pan K, Hurria A, Chlebowski RT. Breast cancer survivorship: state of the science. Breast Cancer Res Treat. 2018 Apr; 168(3):593-600. PMID: 29332134.
      View in: PubMed
    17. Chlebowski RT, Pan K. Complexity of intermittent letrozole adjuvant therapy. Lancet Oncol. 2018 01; 19(1):13-15. PMID: 29158010.
      View in: PubMed
    18. Pan K, Lin EM, Chlebowski RT. Emerging combination endocrine therapies for advanced breast cancer. Breast J. 2018 03; 24(2):214-215. PMID: 28744960.
      View in: PubMed
    19. Chlebowski RT, Pan K, Nananda F. Response. Breast Cancer Res Treat. 2017 06; 163(3):633-634. PMID: 28353060.
      View in: PubMed
    20. Lohmann AE, Goodwin PJ, Chlebowski RT, Pan K, Stambolic V, Dowling RJ. Association of Obesity-Related Metabolic Disruptions With Cancer Risk and Outcome. J Clin Oncol. 2016 12 10; 34(35):4249-4255. PMID: 27903146.
      View in: PubMed
    21. Chlebowski RT, Pan K, Col NF. Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer. Breast Cancer Res Treat. 2017 01; 161(2):185-190. PMID: 27785653.
      View in: PubMed
    22. Pan K, Chlebowski RT, Simon MS, Ray RM, Livaudais-Toman J, Sullivan SD, Stefanick ML, Wallace RB, LeBoff M, Bluhm EC, Paskett ED. Medication use trajectories of postmenopausal breast cancer survivors and matched cancer-free controls. Breast Cancer Res Treat. 2016 Apr; 156(3):567-576. PMID: 27075917.
      View in: PubMed
    23. Chlebowski RT, Pan K. Exemestane with ovarian suppression in premenopausal breast cancer. N Engl J Med. 2014 10 02; 371(14):1358. PMID: 25271612.
      View in: PubMed
    24. Pan K, Chlebowski RT. Adjuvant endocrine therapy of perimenopausal and recently postmenopausal women with hormone receptor-positive breast cancer. Clin Breast Cancer. 2014 Jun; 14(3):147-53. PMID: 24503025.
      View in: PubMed